Mycoplasma pneumonia is a type of pneumonia caused by a bacterium called Mycoplasma pneumoniae. Mycoplasma pneumonia is different from that caused by pneumococcus, and is therefore called atypical pneumonia. It is said that Mycoplasma pneumonia accounts for 30% to 40% of atypical pneumonias. Mycoplasma pneumoniae is the smallest, self-replicating microorganism biologically classified as a bacterium. However, unlike other bacteria, it does not have cell walls.
Mycoplasma pneumonia generally presents with symptoms of cough, fever, headache and malaise, and is indistinguishable from the common cold, a factor that often delays diagnosis and treatment. Mycoplasma pneumonia affects predominantly preschool and school-age children and young adults. The incubation period from infection to onset is generally 1 to 3 weeks, but may extend to 4 weeks. Therefore, the infection can spread in communities such as schools and companies. To prevent the spread of the infection, a reliable diagnosis at an early stage is required.
Testing methods include bacterial isolation, antibody testing, and bacterial DNA detection. However, these methods present problems, such as complicated procedures, requiring special equipment or instruments, and taking time to obtain test results. Compared with these methods, Capilia Mycoplasma allows rapid detection of Mycoplasma pneumoniae, without requiring special skills or instruments.
After completion, Goffin Molecular Technologies will contact you as soon as possible.